RecruitingNot applicableNCT06682962
Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma
Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Okuvision GmbH
- Principal Investigator
- Katrin Lorenz, Prof.Augenklinik und Poliklinik der Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz
- Intervention
- Transcorneal electrical stimulation (TES) with the OkuStim 2 System(device)
- Enrollment
- 50 enrolled
- Eligibility
- 40 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- Augenklinik und Poliklinik der Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Germany
Collaborators
Interdisciplinary Center for Clinical Trials, University Medical Center Mainz · University Medical Center of the Johannes Gutenberg University Mainz, Department of Ophthalmology · Sponsored by the German Federal Ministry of Education and Research (FKZ 13GW0732A)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06682962 on ClinicalTrials.govOther trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07354516Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular HypertensionQlaris Bio, Inc.
- RECRUITINGNCT07303257Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical OptionsHospices Civils de Lyon
- RECRUITINGPHASE1, PHASE2NCT06921317GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle GlaucomaIVIEW Therapeutics Inc.
- ACTIVE NOT RECRUITINGPHASE3NCT07082816Reformulated PG324 Ophthalmic Solution for Intraocular Pressure ReductionAlcon Research
- ACTIVE NOT RECRUITINGPHASE2NCT06030193Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)Qlaris Bio, Inc.
- RECRUITINGPHASE4NCT06848946Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneGlaukos Corporation
- RECRUITINGNCT06691555Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) ShuntDavinci LTD
- RECRUITINGNANCT06607705Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens SensorFundacio Privada Mon Clinic Barcelona
See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma →